BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 18468896)

  • 21. Significance of sentinel lymph node micrometastases in human breast cancer.
    Cox CE; Kiluk JV; Riker AI; Cox JM; Allred N; Ramos DC; Dupont EL; Vrcel V; Diaz N; Boulware D
    J Am Coll Surg; 2008 Feb; 206(2):261-8. PubMed ID: 18222378
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinicopathological factors and nomograms predicting nonsentinel lymph node metastases after neoadjuvant chemotherapy in breast cancer patients.
    Gimbergues P; Abrial C; Durando X; Le Bouedec G; Cachin F; Penault-Llorca F; Mouret-Reynier MA; Kwiatkowski F; Maublant J; Tchirkov A; Dauplat J
    Ann Surg Oncol; 2009 Jul; 16(7):1946-51. PubMed ID: 19408057
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The optimal management of the axillae of patients with microinvasive breast cancer in the sentinel lymph node era.
    Gray RJ; Mulheron B; Pockaj BA; Degnim A; Smith SL
    Am J Surg; 2007 Dec; 194(6):845-8; discussion 848-9. PubMed ID: 18005782
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Axillary reverse mapping: mapping and preserving arm lymphatics may be important in preventing lymphedema during sentinel lymph node biopsy.
    Boneti C; Korourian S; Bland K; Cox K; Adkins LL; Henry-Tillman RS; Klimberg VS
    J Am Coll Surg; 2008 May; 206(5):1038-42; discussion 1042-4. PubMed ID: 18471751
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Factors predicting failure to identify a sentinel lymph node in breast cancer.
    Chagpar AB; Martin RC; Scoggins CR; Carlson DJ; Laidley AL; El-Eid SE; McGlothin TQ; Noyes RD; Ley PB; Tuttle TM; McMasters KM
    Surgery; 2005 Jul; 138(1):56-63. PubMed ID: 16003317
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative analysis of bone marrow micrometastases with sentinel lymph node status in early-stage breast cancer.
    Saha S; Ali S; Ghanem M; Soni M; Wiese D; Arora M; Singh T; Iddings D
    Ann Surg Oncol; 2009 Feb; 16(2):276-80. PubMed ID: 19050967
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of sentinel lymph node biopsy alone and completion axillary lymph node dissection for node-positive breast cancer.
    Bilimoria KY; Bentrem DJ; Hansen NM; Bethke KP; Rademaker AW; Ko CY; Winchester DP; Winchester DJ
    J Clin Oncol; 2009 Jun; 27(18):2946-53. PubMed ID: 19364968
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is routine sentinel lymph node biopsy indicated in women undergoing contralateral prophylactic mastectomy? Magee-Womens Hospital experience.
    Soran A; Falk J; Bonaventura M; Keenan D; Ahrendt G; Johnson R
    Ann Surg Oncol; 2007 Feb; 14(2):646-51. PubMed ID: 17122987
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reoperative sentinel lymph node biopsy in patients with locally recurrent breast cancer.
    Barone JL; Feldman SM; Estabrook A; Tartter PI; Rosenbaum Smith SM; Boolbol SK
    Am J Surg; 2007 Oct; 194(4):491-3. PubMed ID: 17826062
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Microinvasive breast cancer and the role of sentinel node biopsy: an institutional experience and review of the literature.
    Guth AA; Mercado C; Roses DF; Darvishian F; Singh B; Cangiarella JF
    Breast J; 2008; 14(4):335-9. PubMed ID: 18537917
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Histopathologic characteristics of the primary tumor in breast cancer patients with isolated tumor cells of the sentinel node.
    Hulvat M; Rajan P; Rajan E; Sarker S; Schermer C; Aranha G; Yao K
    Surgery; 2008 Oct; 144(4):518-24; discussion 524. PubMed ID: 18847634
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Can magnetic resonance imaging be used to select patients for sentinel lymph node biopsy in prophylactic mastectomy?
    McLaughlin SA; Stempel M; Morris EA; Liberman L; King TA
    Cancer; 2008 Mar; 112(6):1214-21. PubMed ID: 18257089
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictive probability of four different breast cancer nomograms for nonsentinel axillary lymph node metastasis in positive sentinel node biopsy.
    Gur AS; Unal B; Johnson R; Ahrendt G; Bonaventura M; Gordon P; Soran A
    J Am Coll Surg; 2009 Feb; 208(2):229-35. PubMed ID: 19228534
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Axillary recurrence rate after tumour negative and micrometastatic positive sentinel node procedures in breast cancer patients, a population based multicenter study.
    Bulte CS; van der Heiden-van der Loo M; Hennipman A
    Eur J Surg Oncol; 2009 Jan; 35(1):25-31. PubMed ID: 18640809
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sentinel node mapping for breast cancer: the operative experience of a breast surgeon in a rural community.
    Davit FE; Gatmaitan P; Garguilo G
    Am Surg; 2008 May; 74(5):423-7. PubMed ID: 18481500
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Do bone marrow micrometastases correlate with sentinel lymph node metastases in breast cancer patients?
    Trocciola SM; Hoda S; Osborne MP; Christos PJ; Levin H; Martins D; Carson J; Daly J; Simmons RM
    J Am Coll Surg; 2005 May; 200(5):720-5; discussion 725-6. PubMed ID: 15848362
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Factors affecting false-negative breast sentinel node biopsy in Chinese patients.
    Chok KS; Suen DT; Lim FM; Li GK; Kwong A
    ANZ J Surg; 2007 Oct; 77(10):866-9. PubMed ID: 17803550
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Surgical management of the axilla: do intramammary nodes matter?
    Pugliese MS; Stempel MM; Cody HS; Morrow M; Gemignani ML
    Am J Surg; 2009 Oct; 198(4):532-7. PubMed ID: 19800463
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Additional axillary metastases and stage migration in breast cancer patients with micrometastases or submicrometastases in sentinel lymph nodes.
    van Rijk MC; Peterse JL; Nieweg OE; Oldenburg HS; Rutgers EJ; Kroon BB
    Cancer; 2006 Aug; 107(3):467-71. PubMed ID: 16804924
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Implementation of sentinel node biopsy in breast cancer patients in the Netherlands.
    Ho VK; van der Heiden-van der Loo M; Rutgers EJ; van Diest PJ; Hobbelink MG; Tjan-Heijnen VC; Dirx MJ; Reedijk AM; van Dijck JA; van de Poll-Franse LV; Schaapveld M; Peeters PH
    Eur J Cancer; 2008 Mar; 44(5):683-91. PubMed ID: 18314328
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.